Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
Status:
Recruiting
Trial end date:
2030-12-01
Target enrollment:
Participant gender:
Summary
This study suggests that R-IDARAM combined with intrathecal immunochemotherapy may be high
effective in elderly patients with primary central nervous system lymphoma (PCNSL).